We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Molecular Insight Hits USPTO Over Patent Terms

Law360 (December 3, 2008, 12:00 AM EST) -- Molecular Insight Pharmaceuticals Inc. has filed two suits against the U.S. Patent and Trademark Office over its refusal to extend the term patents owned or licensed by the drug company in...
To view the full article, register now.